Clinical-stage pharma developing food-intake therapeutics.
| Date | Round | Amount |
|---|---|---|
| Jan 2024 | Funding round Orexa, a Dutch clinical-stage pharma, raised EUR870K from new and existing investors. | $940K |
| Jan 2023 | Seed Orexa raised EUR485K (investors undisclosed) for its food-intake therapeutics, bringing 12-month total to EUR2.5M. | $485K |
| Aug 2022 | Funding round Dutch life-science company Orexa raised 1.2M euros from informal investors to launch Phase 2 clinical trials of its drug to increase food intake. | $1.2M |